Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.

Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Pharmaceutics Pubmed

Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.

Si, Jingxing; Zhao, Xiaobao; Gao, Shan; Huang, Dongsheng; Sui, Meihua
International Journal of Pharmaceutics , Volume 568: 1 – Jan 24, 2020
Download PDF
Loading next page...
 
/lp/pubmed/advances-in-delivery-of-irinotecan-cpt-11-active-metabolite-7-ethyl-10-u0nK6RLTGD

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2019 Elsevier B.V. All rights reserved.
ISSN
0378-5173
eISSN
1873-3476
DOI
10.1016/j.ijpharm.2019.118499
pmid
31299338

Abstract

Journal

International Journal of Pharmaceutics – Pubmed

Published: Jan 24, 2020

There are no references for this article.